Correlation Between Novo Nordisk and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Novo Nordisk and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Telix Pharmaceuticals.
Diversification Opportunities for Novo Nordisk and Telix Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Novo and Telix is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Novo Nordisk and Telix Pharmaceuticals
Assuming the 90 days horizon Novo Nordisk is expected to generate 8.72 times less return on investment than Telix Pharmaceuticals. In addition to that, Novo Nordisk is 1.08 times more volatile than Telix Pharmaceuticals Limited. It trades about 0.04 of its total potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.37 per unit of volatility. If you would invest 1,513 in Telix Pharmaceuticals Limited on November 5, 2024 and sell it today you would earn a total of 307.00 from holding Telix Pharmaceuticals Limited or generate 20.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Telix Pharmaceuticals Limited
Performance |
| Timeline |
| Novo Nordisk AS |
| Telix Pharmaceuticals |
Novo Nordisk and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Telix Pharmaceuticals
The main advantage of trading using opposite Novo Nordisk and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.| Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |